Prevest Denpro Ltd Q2 FY25 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
N/A
Margin
N/A
Fundraise
N/A
Order
N/A
Capex
N/A
0 of 0 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
See what Prevest Denpro Ltd management said on margin guidance — free account, 30 seconds.
Fundraise plans
See what Prevest Denpro Ltd management said on order book — free account, 30 seconds.
Capex plans
Track Prevest Denpro Ltd — get its next earnings analysis in your feed
How does Prevest Denpro Ltd rank vs peers in Healthcare Equipment & Supplies?
Pro featureHow does Prevest Denpro Ltd rank in Healthcare Equipment & Supplies?
Compare Prevest Denpro Ltd against every Healthcare Equipment & Supplies company (Q2 FY25) on revenue, margins and earnings-call signals.
Continue your research
What Prevest Denpro Ltd's management said in earlier quarters
Others in Healthcare Equipment & Supplies this season
- Galaxy Medicare (Q2 FY27)
Revenue from Operations (₹ Mn): . Key investor presentation takeaways from Galaxy Medicare's Q2 FY27 investor presentation — and how it ranks against sector pee
- Nureca Ltd (Q2 FY27)
Year-on-year growth in revenue from operations: approximately 55% increase (585.99 vs 378.41 million standalone) . Key results statement takeaways from Nureca's
- Aprameya Engineering Ltd (Q2 FY26)
H1FY26 Revenue from Operations: Rs 421.4 Mn, up 343% YoY from Rs 92.7 Mn in H1FY25. Key investor presentation takeaways from Aprameya Engineering Ltd's Q2 FY26
- Nureca Ltd (Q2 FY26)
Q2 FY26 Revenue from Operations: INR 528 million, a 7% year-on-year (YoY) growth from INR 493 million in Q2 FY25. Key investor presentation takeaways from Nurec